Longeveron LLC (LGVN)

Currency in USD
0.661
+0.012(+1.79%)
Real-time Data·
LGVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.6300.671
52 wk Range
0.4751.800
Key Statistics
Prev. Close
0.65
Open
0.65
Day's Range
0.63-0.671
52 wk Range
0.475-1.8
Volume
37.38K
Average Volume (3m)
468.13K
1-Year Change
-48.7597%
Book Value / Share
0.55
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LGVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.150
Upside
+981.69%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Longeveron LLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.150
(+981.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Hold---DowngradeMay 11, 2026
H.C. Wainwright
Buy8.00+1,110.29%10.00MaintainMay 04, 2026

Longeveron LLC Earnings Call Summary for Q1/2026

  • Q1 2026 revenue flat at $0.4M vs. prior year; clinical trial revenue surged 46% as company pivots from contract manufacturing.
  • Net loss improved 6% to $4.7M; operating expenses declined with R&D down 8% and G&A down 7% reflecting cost discipline.
  • Stock fell 5.18% to $0.641 premarket; company secured undisclosed new investment capital to extend operations through Q4 2026.
  • ELPIS II trial data for laromestrocel in Hypoplastic Left Heart Syndrome expected August 2026; FY2026 EPS projected at -$0.86.
  • CEO Willard emphasized strategic focus on core stem cell programs with FDA expedited designations; pursuing licensing partnerships.
Last Updated: 2026-05-19, 08:28 a/m
Read Full Transcript

Earnings

Latest Release
May 13, 2026
EPS / Forecast
-0.19 / -0.32
Revenue / Forecast
398K / --
EPS Revisions
Last 90 days

LGVN Income Statement

Compare LGVN to Peers and Sector

Metrics to compare
LGVN
Peers
Sector
Relationship
P/E Ratio
−0.9x−4.8x−0.4x
PEG Ratio
−0.02−0.070.00
Price/Book
1.3x2.6x2.6x
Price / LTM Sales
17.1x28.6x3.1x
Upside (Analyst Target)
-228.5%48.3%
Fair Value Upside
Unlock−8.7%6.1%Unlock

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer’s disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
862.16K2.77%559.97K
Other Institutional Investors
3.06M9.82%1.99M
Public Companies & Retail Investors
27.23M87.41%17.68M
Total
31.15M100.00%20.23M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Janus Henderson Group plc4.15%1,291,331839
Vanguard Capital Management, LLC1.74%542,032352

People Also Watch

0.7476
PRSO
-6.55%
1.060
BTAI
-3.67%
0.751
HUMA
-2.53%
4.485
HCWB
-2.92%
2.6000
CLRB
-6.14%

FAQ

What Is the Longeveron LLC (LGVN) Stock Price Today?

The Longeveron LLC stock price today is 0.661 USD.

What Stock Exchange Does Longeveron LLC Trade On?

Longeveron LLC is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Longeveron LLC?

The stock symbol for Longeveron LLC is "LGVN."

What Is the Longeveron LLC Market Cap?

As of today, Longeveron LLC market cap is 20.410M USD.

What Is Longeveron LLC's Earnings Per Share (TTM)?

The Longeveron LLC EPS (TTM) is -1.120.

When Is the Next Longeveron LLC Earnings Date?

Longeveron LLC will release its next earnings report on Aug 07, 2026.

From a Technical Analysis Perspective, Is LGVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Longeveron LLC Stock Split?

Longeveron LLC has split 1 times.

How Many Employees Does Longeveron LLC Have?

Longeveron LLC has 38 employees.

What is the current trading status of Longeveron LLC (LGVN)?

As of Jul 07, 2026, Longeveron LLC (LGVN) is trading at a price of 0.661 USD, with a previous close of 0.650 USD. The stock has fluctuated within a day range of 0.630 USD to 0.671 USD, while its 52-week range spans from 0.475 USD to 1.800 USD.

What Is Longeveron LLC (LGVN) Price Target According to Analysts?

The average 12-month price target for Longeveron LLC is 7.150 USD, with a high estimate of 10.45 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +981.69% Upside potential.

What Is the LGVN Premarket Price?

LGVN's last pre-market stock price is 0.661 USD. The pre-market share volume is 4,270.000, and the stock has decreased by 0.011, or 1.690%.

What Is the LGVN After Hours Price?

LGVN's last after hours stock price is 0.634 USD, the stock has decreased by -0.016, or -2.460%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.